This is a discussion on Cisplatin-Based Chemo Improves Post-Op Survival in NSCLC within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; After complete resection of non-small cell lung cancer (NSCLC), there is a significant improvement in survival when cisplatin-based ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
After complete resection of non-small cell lung cancer (NSCLC), there is a significant improvement in survival when cisplatin-based chemotherapy is administered, according to results of a meta-analysis involving more than 4,500 patients.
Reuters Health Information More... |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Initial Chemo Beneficial in Lung Cancer Brain Metastasis | industry_news | Other Clinical Pharmacy News | 0 | 08-07-2008 02:21 PM |
| Long-Term Data Confirm Rituximab Plus Chemo in Follicular Lymphoma | industry_news | Other Clinical Pharmacy News | 0 | 07-31-2008 02:22 PM |
| Kidney Disease Linked to Lower Medication Use Post-MI | industry_news | Other Clinical Pharmacy News | 0 | 07-19-2008 09:57 AM |
| Pharmacogenomics-Based Treatment of Helicobacter pylori Infection | industry_news | Updates from the Technology Assessment Authorities | 0 | 05-23-2008 04:59 PM |
| Infrastructure to Monitor Utilization and Outcomes of Gene-Based Applications: An Assessment | industry_news | Comparative Effectiveness Updates | 0 | 05-21-2008 02:27 PM |